REQUEST A DEMO
Total
USD $0.00
Search more companies

Surgivasc S A S (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Surgivasc S A S Profile Updated: May 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Surgivasc S A S is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on March 09, 2012. It currently has a total number of 10 (2022) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 32.05% in 2024. Its total assets grew by 12.57% over the same period. In 2024, Surgivasc S A S’s net profit margin decreased by 11.19%.

Headquarters
Cl 175 15-20 To 2 Apto 1702
Bogota D.C.; Bogota D.C; Postal Code: 1025

Contact Details: Purchase the Surgivasc S A S report to view the information.

Basic Information
Total Employees:
Purchase the Surgivasc S A S report to view the information.
Registered Capital:
Purchase the Surgivasc S A S report to view the information.
Financial Auditors:
Purchase the Surgivasc S A S report to view the information.
Incorporation Date:
March 09, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Surgivasc S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-32.05%
Total operating revenue
-29.31%
Operating profit (EBIT)
-35.18%
EBITDA
-33.78%
Net Profit (Loss) for the Period
-57.75%
Total Assets
12.57%
Total Equity
0.66%
Operating Profit Margin (ROS)
-1.42%
Net Profit Margin
-11.19%
Return on Equity (ROE)
-11.81%
Debt/Equity
-0.27%
Quick Ratio
-0.78%
Cash Ratio
-1.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?